BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3258663)

  • 1. Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease.
    Ngo KY; Glotz VT; Koziol JA; Lynch DC; Gitschier J; Ranieri P; Ciavarella N; Ruggeri ZM; Zimmerman TS
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2753-7. PubMed ID: 3258663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.
    Mancuso DJ; Tuley EA; Castillo R; de Bosch N; Mannucci PM; Sadler JE
    Thromb Haemost; 1994 Aug; 72(2):180-5. PubMed ID: 7831648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene deletions correlate with the development of alloantibodies in von Willebrand disease.
    Shelton-Inloes BB; Chehab FF; Mannucci PM; Federici AB; Sadler JE
    J Clin Invest; 1987 May; 79(5):1459-65. PubMed ID: 3033024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual.
    Peake IR; Liddell MB; Moodie P; Standen G; Mancuso DJ; Tuley EA; Westfield LA; Sorace JM; Sadler JE; Verweij CL
    Blood; 1990 Feb; 75(3):654-61. PubMed ID: 2297569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A de novo and heterozygous gene deletion causing a variant of von Willebrand disease.
    Bernardi F; Marchetti G; Guerra S; Casonato A; Gemmati D; Patracchini P; Ballerini G; Conconi F
    Blood; 1990 Feb; 75(3):677-83. PubMed ID: 1967540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous C2362F von Willebrand factor induces intracellular retention of mutant von Willebrand factor resulting in autosomal recessive severe von Willebrand disease.
    Tjernberg P; Castaman G; Vos HL; Bertina RM; Eikenboom JC
    Br J Haematol; 2006 May; 133(4):409-18. PubMed ID: 16643449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3.
    Schneppenheim R; Castaman G; Federici AB; Kreuz W; Marschalek R; Oldenburg J; Oyen F; Budde U
    J Thromb Haemost; 2007 Apr; 5(4):722-8. PubMed ID: 17371490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.
    Zhang ZP; Lindstedt M; Falk G; Blombäck M; Egberg N; Anvret M
    Am J Hum Genet; 1992 Oct; 51(4):850-8. PubMed ID: 1415226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of gene mutation and genetic analysis of a patient with type 3 von Willebrand disease].
    Li Z; Wang Y; Wan H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):122-4. PubMed ID: 11243141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Q1311X: a novel nonsense mutation of putative ancient origin in the von Willebrand factor gene.
    Casaña P; Martínez F; Haya S; Lorenzo JI; Espinós C; Aznar JA
    Br J Haematol; 2000 Nov; 111(2):552-5. PubMed ID: 11122100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.
    Anvret M; Blombäck M; Lindstedt M; Söderlind E; Tapper-Persson M; Thelander AC
    Hum Genet; 1992 May; 89(2):147-54. PubMed ID: 1350262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First application of MLPA method in severe von Willebrand disease. Confirmation of a new large VWF gene deletion and identification of heterozygous carriers.
    Cabrera N; Casaña P; Cid AR; Moret A; Moreno M; Palomo A; Aznar JA
    Br J Haematol; 2011 Jan; 152(2):240-2. PubMed ID: 20955405
    [No Abstract]   [Full Text] [Related]  

  • 15. Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene.
    Peake IR; Bowen D; Bignell P; Liddell MB; Sadler JE; Standen G; Bloom AL
    Blood; 1990 Aug; 76(3):555-61. PubMed ID: 2378985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenotype and genotype analysis of three Chinese pedigrees with von Willebrand disease].
    Qin HH; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):99-102. PubMed ID: 21429375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
    Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
    Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.
    Nichols WC; Lyons SE; Harrison JS; Cody RL; Ginsburg D
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3857-61. PubMed ID: 1673793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.
    Schneppenheim R; Brassard J; Krey S; Budde U; Kunicki TJ; Holmberg L; Ware J; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3581-6. PubMed ID: 8622978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1584 in von Willebrand factor is necessary for enhanced proteolysis by ADAMTS13 in vitro.
    Keeney S; Grundy P; Collins PW; Bowen DJ
    Haemophilia; 2007 Jul; 13(4):405-8. PubMed ID: 17610557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.